Headache, nausea, confusion or drowsiness — signs of water intoxication and dangerously low blood sodium, a real risk with this hormone.
Stop, and do not load up on water. Get assessed.
Confusion, a seizure, or collapse → 911.
Allergic reaction: hives, swelling of the lips, tongue or throat, wheezing or dizziness can escalate to anaphylaxis within minutes — call 911 immediately. Site infection: spreading redness, heat, swelling, pus or fever is not wait-and-see; an abscess or cellulitis can need drainage or IV antibiotics. Unverified product: grey-market vials are frequently mislabelled or contaminated, so a reaction may be to endotoxin or the wrong contents, not the named compound.
A nine-amino-acid hormone synthesised in the hypothalamus and released from the posterior pituitary. Peripherally it drives uterine contraction and milk ejection through OXTR-mediated calcium signalling. Centrally it modulates social recognition, pair bonding and stress responses — the basis of an enormous and frequently overstated literature. It differs from vasopressin by just two amino acids, and cross-reacts with vasopressin receptors, which is the source of several of its clinical hazards.
The obstetric use is beyond dispute and decades old. The psychiatric literature — intranasal oxytocin for autism, social anxiety, PTSD — is a cautionary tale: early small studies were striking, larger and better-controlled trials have been largely negative, and whether meaningful quantities of intranasal oxytocin even reach the brain remains genuinely unsettled.
FDA-approved (injection) for labour induction and control of postpartum bleeding. Prescription-only. Intranasal formulations for social or psychiatric use are not approved and are compounded or sold illicitly.
The approved use carries a boxed warning against elective induction. Real hazards: uterine hyperstimulation and rupture, and — through vasopressin receptor cross-reactivity — water intoxication with hyponatraemia, seizures and death. This is not a benign “love hormone”; it is a potent obstetric drug.
Approved injection: weight- and protocol-based IV infusion for labour, given only in hospital with monitoring. Intranasal 'social/psychiatric' use has no established, validated dose.
Reported from clinical trials or FDA labelling as a matter of record. It is not a recommendation, and for unapproved compounds no dose has been shown safe or effective in humans.
Above is what was administered in trials or on FDA labels, reported as fact. We do not convert it into a personal protocol, calculate a dose for your body weight, or tell you what to inject or how to reconstitute it — that decision belongs with a licensed physician. See our editorial policy.
Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.